ETF · holdings as filed 2026-03-31

What's inside IHE?

iShares U.S. Pharmaceuticals ETF
Holdings
59
positions in the fund
Top 10
76%
of fund assets
Expense ratio
0.38%
net, per year
Fund size
$1B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
J
JNJJOHNSON & JOHNSON
22.07%
2
L
LLYELI LILLY & CO
20.18%
3
M
MRKMERCK & CO. INC.
4.54%
4
P
PFEPFIZER INC
4.51%
5
R
RPRXROYALTY PHARMA PLC- CL A
4.51%
6
B
BMYBRISTOL-MYERS SQUIBB CO
4.44%
7
Z
ZTSZOETIS INC
4.33%
8
V
VTRSVIATRIS INC
4.17%
9
E
ELANELANCO ANIMAL HEALTH INC
3.18%
10
J
JAZZJAZZ PHARMACEUTICALS PLC
3.08%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
J
JNJJOHNSON & JOHNSON
22.07%
2
L
LLYELI LILLY & CO
20.18%
3
M
MRKMERCK & CO. INC.
4.54%
4
P
PFEPFIZER INC
4.51%
5
B
BMYBRISTOL-MYERS SQUIBB CO
4.44%
6
Z
ZTSZOETIS INC
4.33%
7
B
BISXXBCF INSTITUTIONAL-SL AGNCY
4.17%
8
V
VTRSVIATRIS INC
4.17%
9
E
ELANELANCO ANIMAL HEALTH INC
3.18%
10
A
AXSMAXSOME THERAPEUTICS INC
1.92%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold IHE alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.